Foamix Pharmaceuticals Ltd. Marketable Securities (Current)
Foamix Pharmaceuticals Ltd. had Marketable Securities (Current) of $16.25 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2020-03-12
- 2019-12-31: Marketable Securities, Current $16.25M.
- 2019-09-30: Marketable Securities, Current $15.33M.
- 2019-06-30: Marketable Securities, Current $14.09M.
- 2019-03-31: Marketable Securities, Current $39.12M.
| Period end | Marketable Securities, Current |
|---|---|
| 2019-12-31 | $16.25M 10-K · filed 2020-03-12 |
| 2019-09-30 | $15.33M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $14.09M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $39.12M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $46.67M 10-K · filed 2020-03-12 |
| 2018-09-30 | $15.04M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $22.83M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $28.58M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $31.80M 10-K · filed 2019-02-28 |
| 2017-06-30 | $30.73M 6-K · filed 2017-08-08 |
| 2016-12-31 | $43.27M 10-K · filed 2018-03-01 |
| 2016-06-30 | $27.20M 6-K · filed 2016-08-10 |
| 2015-12-31 | $23.69M 20-F · filed 2017-02-21 |
| 2014-12-31 | $6.96M 20-F · filed 2016-03-02 |
| 2013-12-31 | $561.00K 20-F · filed 2015-03-17 |